Work

Advances in adjuvant systemic therapy for non-small-cell lung cancer

Year: 2014
Type: review
Abstract: Non-small-cell lung cancer remains a leading cause of death around the world. For most cases, the only chance of cure comes from resection for localised disease, however relapse rates remain high following surgery. Data has emerged over recent years regarding the utility of adjuvant chemotherapy for improving disease-free and overall survival of patients following curative resection. This paper reviews the clinical trials that have been conducted in this area along with the studies integrating radiation therapy in the adjuvant setting. The role of prognostic gene signatures are reviewed as well as ongoing clinical trials including those incorporating biological or targeted therapies.
Authors: David Leong, Rajat Rai, Brandon Nguyen, Andrew Lee, Desmond Yip
Institution: Canberra Hospital
Language: English
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W2002391971
FWCI: 0.821
Cites: 75
Cited by: 21
Related to: 10